Effects of early decrease in oxidative stress after medical therapy in patients with class IV congestive heart failure

被引:14
作者
Castro, PF
Díaz-Araya, G
Nettle, D
Corbalán, R
Pérez, O
Nazzal, C
Larrain, G
Lavandero, S
机构
[1] Pontificia Univ Catolica Chile, Dept Cardiovasc Dis, Fac Med, Santiago, Chile
[2] Univ Chile, Dept Chem Pharmacol & Toxicol, Fac Chem & Pharmaceut Sci, Santiago, Chile
[3] Univ Chile, Dept Biochem & Mol Biol, Fac Chem & Pharmaceut Sci, Santiago, Chile
关键词
D O I
10.1016/S0002-9149(01)02211-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
It has been reported that patients with congestive heart failure (CHF) have increased breath pentane content, conjugated diene levels, and plasma malondialdehyde (MDA) levels, an indirect marker of lipid peroxidation.(1-3) Ghatak et al(4) found that patients with chronic CHF had increased MDA and superoxide levels, which correlated with the severity of the CHF. Low glutathione levels and superoxide dismutase (SOD) activity have also been reported.(5,6) There have been no studies in human refractory CHF to evaluate the impact of acute intensive medical therapy on oxidative stress status and antioxidant enzyme activity. We determined the plasma levels of MDA, SOD, catalase (CAT), and glutathione peroxidase (GSH-Px) activities before and after therapeutic intervention in patients with chronic advanced CHF and refractory symptoms (New York Heart Association functional class IV).
引用
收藏
页码:236 / +
页数:6
相关论文
共 17 条
[1]  
BEERS RF, 1952, J BIOL CHEM, V195, P133
[2]  
CORBALAN R, 1987, REV MED CHILE, V115, P1130
[3]   Antioxidant effects of 1,4-dihydropyridine and nitroso aryl derivatives on the Fe+3/ascorbate-stimulated lipid peroxidation in rat brain slices [J].
Díaz-Araya, G ;
Godoy, L ;
Naranjo, L ;
Squella, JA ;
Letelier, ME ;
Núñez-Vergara, L .
GENERAL PHARMACOLOGY, 1998, 31 (03) :385-391
[4]   Increased malondialdehyde in peripheral blood of patients with congestive heart failure [J].
DiazVelez, CR ;
GarciaCastineiras, S ;
MendozaRamos, E ;
HernandezLopez, E .
AMERICAN HEART JOURNAL, 1996, 131 (01) :146-152
[5]   Oxy free radical system in heart failure and therapeutic role of oral vitamin E [J].
Ghatak, A ;
Brar, MJS ;
Agarwal, A ;
Goel, N ;
Rastogi, AK ;
Vaish, AK ;
Sircar, AR ;
Chandra, M .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 1996, 57 (02) :119-127
[6]  
GILVERTZ MM, 1998, LANCET, V352, P34
[7]   Increased oxidative stress in patients with congestive heart failure [J].
Keith, M ;
Geranmayegan, A ;
Sole, MJ ;
Kurian, R ;
Robinson, A ;
Omran, AS ;
Jeejeebhoy, KN .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (06) :1352-1356
[8]   HEART-FAILURE IN OUTPATIENTS - A RANDOMIZED TRIAL OF DIGOXIN VERSUS PLACEBO [J].
LEE, DCS ;
JOHNSON, RA ;
BINGHAM, JB ;
LEAHY, M ;
DINSMORE, RE ;
GOROLL, AH ;
NEWELL, JB ;
STRAUSS, HW ;
HABER, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 306 (12) :699-705
[9]  
MCCORD JM, 1969, J BIOL CHEM, V244, P6049
[10]   EVIDENCE OF OXIDATIVE STRESS IN CHRONIC HEART-FAILURE IN HUMANS [J].
MCMURRAY, J ;
CHOPRA, M ;
ABDULLAH, I ;
SMITH, WE ;
DARGIE, HJ .
EUROPEAN HEART JOURNAL, 1993, 14 (11) :1493-1498